Results 251 to 260 of about 731,751 (310)

Tenapanor for Irritable Bowel Syndrome With Constipation (IBS-C): A Systematic Review of Randomized Trials Assessing Food and Drug Administration (FDA) Composite Response, Durability, and Risk-of-Bias (RoB-2). [PDF]

Cureus
Al-Juhani A, Desoky MS, Nasir Ahmad M, Alharthi A, Alkabkabi RA, Suhaqi L, Alzahrani JH, Alotibi TA, Almadih F, Desoky R.   +9 more
europepmc   +1 more source

Transforming medical education: Embracing innovative animal simulation in compliance with Food and Drug Administration Modernization Act 2.0 guidelines

Shirish Joshi, Jay Maradia, Rajmohan Seetharaman, Amitoj Sohal   +3 more
openalex   +1 more source

Nanomaterial‐Enhanced Biosensing: Mechanisms and Emerging Applications

Advanced Healthcare Materials, EarlyView.
Nanomaterial integration transforms biosensor capabilities through enhanced signal transduction, sensitivity, and selectivity. This review analyzes how nanoscale materials—from nanoparticles to nanosheets—leverage unique physicochemical properties to revolutionize electrochemical, optical, and electrical biosensing.
Younghak Cho, Yunyoung Choi, Yerim Jang, Hyejeong Seong   +3 more
wiley   +1 more source

Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023. [PDF]

Biomedicines
Martins AC, Oshiro MY, Albericio F, de la Torre BG.   +3 more
europepmc   +1 more source

Advanced Oral Delivery Systems for Nutraceuticals

Advanced Healthcare Materials, EarlyView.
Emerging delivery technologies are explored to overcome barriers to oral nutraceutical absorption. Traditional carriers are compared with novel platforms including biodegradable polymers, MOFs, MPNs, and 3D printing. These systems enhance bioavailability, control release, and enable personalized nutrition.
Xin Yang, Linzixuan Zhang, Zhiling Zheng, Robert Langer, Ana Jaklenec   +4 more
wiley   +1 more source

Safety assessment of dexmedetomidine: Real-world adverse event analysis from the Food and Drug Administration Adverse Events Reporting System public dashboard.

Indian J Pharmacol
Yin Y, Jiang J, Jin Y.
europepmc   +1 more source

Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis

Advanced Healthcare Materials, EarlyView.
This review highlights the potential of organ‐on‐a‐chip systems for studying comorbidities, using chronic kidney disease (CKD) and osteoarthritis (OA) as examples. It summarizes recent advances in kidney‐on‐a‐chip and joint‐on‐a‐chip models and discusses their current and potential application in investigating CKD, OA, and CKD‐OA comorbidity, aiming to
Mingying Han, Weiping Lin, Yuanxiong Cao, Patricia Murray, Bettina Wilm, Stephen J McWilliam, Jude Curran, Ruoxiao Xie   +7 more
wiley   +1 more source

Evaluation of Safety of Elacestrant in Patients with Breast Cancer: Insights from Food and Drug Administration Adverse Event Reporting System Database Analysis. [PDF]

Breast Care (Basel)
Lv T, Bao W, Chen S.
europepmc   +1 more source

Synthetic Antiferromagnetic Designer Nanodisks for High‐Performance Magnetic Separation

Advanced Healthcare Materials, EarlyView.
Micromagnetic‐modeling‐based design and scalable fabrication of synthetic antiferromagnet (SAF) magnetic disk particles (MDPs) using sputter deposition enable high‐performance magnetic separation. The SAF MDPs achieve high colloidal stability and magnetic responsiveness and enable efficient magnetic separation, outperforming conventional particles ...
Subas Scheibler, Sebastian Habermann, Alexander Gogos, Santiago Helbig, Lukas R. H. Gerken, Anna L. Neuer, Vera M. Kissling, Michal Krupinski, Mohammad Alinezhadfar, Rowena Crockett, Nico Kummer, Erik M. Mayr, Dieter Süss, Hans J. Hug, Inge K. Herrmann   +14 more
wiley   +1 more source

Abemaciclib-associated kidney injuries: A retrospective analysis of the United States Food and Drug Administration adverse events reporting system. [PDF]

J Int Med Res
Xu X, Guo X, Chen J, Pan Y, Li J, Chen J, Lai W, Lin L.   +7 more
europepmc   +1 more source